<?xml version="1.0" ?>
<document id="30155490">
  <sentence id="30155490.s0" text="protein polyubiquitination-122, the expression of which is regulated by several transcription factors, such as natural killer cell differentiation, was recently reported to be associated with type 2 diabetes (T2DM) and hepatocellular carcinoma.">
    <entity charOffset="0-26" id="30155490.s0.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="111-146" id="30155490.s0.e1" ontology_id="GO_0001779" text="natural killer cell differentiation" type="GO"/>
    <entity charOffset="219-243" id="30155490.s0.e2" ontology_id="HP_0001402" text="hepatocellular carcinoma" type="HP"/>
    <pair e1="30155490.s0.e0" e2="30155490.s0.e2" id="30155490.s0.p0" relation="false"/>
    <pair e1="30155490.s0.e1" e2="30155490.s0.e2" id="30155490.s0.p1" relation="false"/>
  </sentence>
  <sentence id="30155490.s1" text="Lower serum protein polyubiquitination-122 is a unique feature of natural killer cell differentiation-protein phosphorylation patients and might partially explain the increased risk for liver neoplasm and abnormal lipid metabolism in HNF1A-DM patients">
    <entity charOffset="12-38" id="30155490.s1.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="66-101" id="30155490.s1.e1" ontology_id="GO_0001779" text="natural killer cell differentiation" type="GO"/>
    <entity charOffset="102-125" id="30155490.s1.e2" ontology_id="GO_0006468" text="protein phosphorylation" type="GO"/>
    <entity charOffset="192-200" id="30155490.s1.e3" ontology_id="HP_0002664" text="neoplasm" type="HP"/>
    <pair e1="30155490.s1.e0" e2="30155490.s1.e3" id="30155490.s1.p0" relation="false"/>
    <pair e1="30155490.s1.e1" e2="30155490.s1.e3" id="30155490.s1.p1" relation="true"/>
    <pair e1="30155490.s1.e2" e2="30155490.s1.e3" id="30155490.s1.p2" relation="false"/>
  </sentence>
</document>
